The developmental and epileptic encephalopathies (DEEs) market is experiencing growth due to the increasing recognition of these rare, severe neurological disorders, which are often characterized by developmental delay and intractable epilepsy. DEEs typically manifest in infancy or early childhood and lead to significant cognitive impairment and other neurological complications. As awareness...